Evidence map›Paper›PMID 40034953›Full record

ArticleCancer diagnosis & prognosis

Clinicopathological Features and Prognosis of Unresectable Colorectal Cancer With the

Yukari Ono, Koji Numata, Kenta Iguchi, Mamoru Uchiyama, Masahiro Asari, Yasushi Rino, Aya Saito, Manabu Shiozawa

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer diagnosis & prognosis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yukari OnoDepartment of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Koji NumataDepartment of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Kenta IguchiDepartment of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Mamoru UchiyamaDepartment of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Masahiro AsariDepartment of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Yasushi RinoDepartment of Surgery, Yokohama City University, Yokohama, Japan.
Aya SaitoDepartment of Surgery, Yokohama City University, Yokohama, Japan.
Manabu ShiozawaDepartment of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/Aim: Patients with unresectable advanced and recurrent colorectal cancer (CRC) and the Patients and methods: We examined clinicopathological characteristics and treatment outcomes of 26 patients with Results: The mean age was 63.1±14.0 years; out of 26 patients, nine (34.6%) were female, 12 (46.2%) had right-sided CRC, and eight (30.8%) had poorly differentiated or mucinous adenocarcinoma. One patient (3.8%) had a Conclusion: The

Indexed as

Beacon CRC trialbinimetinibB-rafBRAF V600Eencorafenibmutationproto-oncogeneUnresectable advanced recurrent colorectal cancer

Identifiers

PMID40034953
PMCPMC11871857

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.